RecruitingPhase III🇵🇱 PolandEN original

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

This is a Phase III trial where participants will be randomized to two treatment groups, which means participants will be assigned by equal chance to a treatment group. This trial will be double-blinded, which means neither the participants nor the trial doctors will know which of the two treatments the participants actually receive. Participants will receive either the trial drug with chemotherapy or placebo (which looks like the trial drug but does not have any drug in it) with chemotherapy.

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • Nie kwalifikujesz się do standardowego leczenia immunoterapią plus chemioterapią ze względu na poziom ekspresji PD-L1 w guzie
  • Masz zaawansowanego raka piersi (miejscowo nieoperacyjnego lub z przerzutami) - type triple-negative lub typ z niskim stężeniem receptora estrogenowego
  • Masz co najmniej jeden widoczny guz do badania (mierzalny w badaniach obrazowych)
  • Dostarczyłeś próbkę tkanki guza (archiwalną lub świeżą) do badań
  • Twój ogólny stan zdrowia pozwala na uczestnictwo w badaniu (skala ECOG 0-1)

✗ Disqualifies

  • Otrzymałeś chemioterapię lub immunoterapię na zaawansowany rak w przeszłości
  • Otrzymałeś wcześniej leczenie lekiem bispecyficznym przeciwko PD(L)1 i VEGF
  • Przyjmujesz wysokie dawki sterydów (powyżej 10 mg predniozonu dziennie) w ciągu ostatnich 7 dni
  • Otrzymałeś szczepienie żywą szczepionką w ostatnich 4 tygodniach
  • Dostawałeś silne antybiotyki dożylnie w ostatnich 2 tygodniach
  • Jesteś w ciąży, karmisz piersią lub planujesz ciążę w ciągu badania i 6 miesięcy po
  • Miałeś dużą operację, uraz lub zabieg dentystyczny w ostatnich 28 dniach
  • Przeszedłeś przeszczep szpiku lub narządu

Simplified criteria — AI translation

Trial details

Minimum age
18 Years
Last updated (source)
June 25, 2026
Sex
No restrictions

Therapies / drugs in trial

Locations (143)

Highlands Oncology Group

Springdale, United States

University Of California - San Diego Moores Cancer Center

La Jolla, United States

Cedar Sinai - Samuel Oschin Cancer Center

Los Angeles, United States

Stanford University School of Medicine - Stanford Cancer Institute (SCI) - Stanford Women's Cancer Center

Palo Alto, United States

Sacred Heart Medical Oncology Group

Pensacola, United States

Cancer Care Specialists

Decatur, United States

Cancer Care Specialists of Illinois

O'Fallon, United States

Carle Foundation Hospital d/b/a Carle Cancer Center

Urbana, United States

University Medical Center, Inc. DBA University of Louisville Hospital/James Graham Brown Cancer Center

Louisville, United States

New England Cancer Specialists

Westbrook, United States

Saint Agnes Hospital, Clinical Research Center

Baltimore, United States

Lahey Hospital & Medical Center

Burlington, United States

Karmanos Cancer Center

Detroit, United States

Profound Research LLC at Michigan Hematology and Oncology Consultants

Royal Oak, United States

Saint Luke's Hospital of Kansas City

Kansas City, United States

Oncology Hematology West, PC dba Nebraska Cancer Specialist

Grand Island, United States

Paradigm Oncology Hematology West P.C. dba Nebraska Cancer Specialists

Omaha, United States

Summit Medical Group PA

Florham Park, United States

Paradigm New York Cancer and Blood Specialists

Bay Shore, United States

Paradigm New York Cancer and Blood Specialists

New York, United States

Paradigm New York Cancer and Blood Specialists

New York, United States

Paradigm New York Cancer and Blood Specialists

New York, United States

Paradigm New York Cancer and Blood Specialists

New York, United States

Paradigm New York Cancer and Blood Specialists

New York, United States

Paradigm New York Cancer and Blood Specialists

New York, United States

Paradigm New York Cancer and Blood Specialists

New York, United States

Paradigm New York Cancer and Blood Specialists

New York, United States

Rochester General Hospital Lipson Cancer Institute

Rochester, United States

Stony Brook University Medical Center

Stony Brook, United States

Montefiore Medical Center

The Bronx, United States

Oncology Specialists of Charlotte Pa

Charlotte, United States

Carolina Oncology Specialists

Charlotte, United States

St Charles Bend Cancer Center

Bend, United States

St. Charles Cancer Center - Redmond

Redmond, United States

Oregon Oncology Specialists

Salem, United States

The West Clinic, P.C. dba West Cancer Center

Germantown, United States

UT Southwestern Medical Center at Redbird

Dallas, United States

University Of Texas Southwestern Medical Center

Dallas, United States

UT Southwestern Moncrief Cancer Institute

Fort Worth, United States

Oncology Consultants PA

Houston, United States

Oncology Consultants PA

Houston, United States

UT Southwestern Medical Center at Richardson/Plano

Richardson, United States

Bon Secours Cancer Institute at Memorial Regional

Mechanicsville, United States

Bon Secours St. Francis Medical Center

Midlothian, United States

Bon Secours Cancer Institute at St. Mary's

Richmond, United States

Northwest Medical Specialties, PLLC

Tacoma, United States

Medical College of Wisconsin

Milwaukee, United States

St Vincent's Hospital - The Kinghorn Cancer Centre

Darlinghurst, Australia

GenesisCare St Andrew's Precinct

Adelaide, Australia

Peninsula & South Eastern Hematology and Oncology Group

Frankston, Australia

Peter MacCallum Cancer Centre

Melbourne, Australia

Monash University - Monash Medical Centre (MMC) - Clayton

Melbourne, Australia

Westmead Hospital

Westmead, Australia

Imeldaziekenhuis

Bonheiden, Belgium

Universitair Ziekenhuis Brussel (AZ-VUB - Academisch Ziekenhuis der Vrije Universiteit Brussel)

Brussels, Belgium

Grand hospital de Charleroi

Gilly, Belgium

University Hospitals Leuven

Leuven, Belgium

Universite Catholique de Louvain (UCL) - Cliniques Universitaires Saint-Luc

Woluwe-Saint-Lambert, Belgium

Impar Servicos Hospitalares S/A - Hospital Brasilia

Brasília, Brazil

Unidade de Pesquisa Clinica em Oncologia Ltda (UPCO) (Clinica Lacks)

Pelotas, Brazil

Perola Centro de Pesquisa em Oncologia

São Paulo, Brazil

Associacao Feminina de Educacao e Combate ao Cancer(AFECC) - Hospital Santa Rita

Vitória, Brazil

Changde First People's Hospital

Changde, China

Shandong Cancer Hospital And Institute

Jinan, China

Linyi Cancer Hospital

Linyi, China

Jiangsu Peoples Hospital

Nanjing, China

Fudan University - Shanghai Cancer Center (FUSCC)

Shanghai, China

The First Affiliated Hospital of Zhengzhou University

Zhengzhou, China

KOC Pardubickeho kraje Multiscan-Pardubicka nemocnice

Pardubice, Czechia

Fakultni Thomayerova nemocnice

Prague, Czechia

Fakultni nemocnice Motol a Homolka

Prague, Czechia

High Technology Hospital Medcenter LTD

Batumi, Georgia

Multiprofile Clinic Consilium Medulla

Tbilisi, Georgia

LLC Todua Clinic

Tbilisi, Georgia

Caucasus Medical Centre

Tbilisi, Georgia

Hämatologische-Onkologische Praxis Augsburg

Augsburg, Germany

Onkologisch-Haematologische Schwerpunktpraxis

Bremen, Germany

Praxis Fuer Interdisziplinaere Onkologie & Haematologie

Freiburg im Breisgau, Germany

SRH Wald-Kliniken Gera GmbH

Gera, Germany

Mammazentrum Hamburg - Brustklinik am Krankenhaus Jerusalem

Hamburg, Germany

Institut fuer Versorgungsforschung in der Onkologie

Koblenz, Germany

Klinikum Nürnberg Nord

Nuremberg, Germany

Centro di Riferimento Oncologico (CRO)

Aviano, Italy

Azienda Unità Sanitaria Locale 2 (USL2) Lucca

Lucca, Italy

Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) - Ospedale San Raffaele (HSR) (Istituto Scientifico Universitario San Raffaele)

Milan, Italy

Fondazione IRCCS Istituto Nazionale dei Tumori

Milan, Italy

IRCCS-Istituto Europeo di Oncologia

Milan, Italy

ASST Monza-Azienda Ospedaliera San Gerardo

Monza, Italy

Fondazione Policlinico Universitario Campus Bio-Medico

Roma, Italy

Azienda Ospedaliero Universitaria Ospedali Riuniti Umberto I

Torrette, Italy

Chiba Cancer Center

Chiba, Japan

Fukushima Medical University Hospital

Fukushima, Japan

Gifu University Hospital

Gifu, Japan

Hiroshima City Hiroshima Citizens Hospital

Hiroshima, Japan

Hakuaikai Medical Corporation Sagara Hospital

Kagoshima, Japan

Kumamoto University Hospital

Kumamoto, Japan

Kyoto University Hospital

Kyoto, Japan

National Hospital Organization Shikoku Cancer Center

Matsuyama, Japan

Nagoya City University Hospital

Nagoya, Japan

Kindai University Hospital

Sakai, Japan

Tohoku University Hospital

Sendai, Japan

National Center For Global Health And Medicine

Shinjuku-Ku, Japan

Uniwersyteckie Centrum Kliniczne

Gdansk, Poland

IP Clinic Sp. z o.o.

Lodz, Poland

Narodowy Insytut Onkologii im. Marii Sklodowskiej-Curie - Państwowy Instytut Badawczy

Warsaw, Poland

Wojskowy Instytut Medyczny Panstwowy Instytut Badawczy

Warsaw, Poland

Soon Chun Hyang University Cheonan Hospital

Cheonan, South Korea

Chungbuk National University Hospital

Cheongju-si, South Korea

National Cancer Center

Goyang-si, South Korea

Seoul National University Bundang Hospital (SNUBH)

Seongnam-si, South Korea

Korea University Anam Hospital

Seoul, South Korea

Severance Hospital, Yonsei University Health System

Seoul, South Korea

Asan Medical Center (AMC)

Seoul, South Korea

Samsung Medical Center

Seoul, South Korea

Ajou University Hospital

Suwon, South Korea

Hospital Universitario de Badajoz

Badajoz, Spain

Parc de Salut Mar - Hospital del Mar

Barcelona, Spain

Institut Oncologic Rosell - Hospital General De Catalunya

Barcelona, Spain

Hospital Universitario Reina Sofia

Córdoba, Spain

IOB Institute of Oncology - Beata Maria Ana Hospital

Madrid, Spain

Universidad de Navarra - Clinica Universidad de Navarra (CUN)

Madrid, Spain

Hospital Universitario Fundación Jiménez Díaz

Madrid, Spain

Hospital Universitario Madrid Sanchinarro - Centro Integral Oncologico Clara Campal (CIOCC)

Madrid, Spain

Hospital General Universitario Morales Meseguer

Murcia, Spain

Hospital Universitario Virgen De La Arrixaca (Huva)

Murcia, Spain

Universidad de Navarra - Clínica Universidad de Navarra (CUN)

Pamplona, Spain

Hospital Universitari Parc Tauli

Sabadell, Spain

Fundación Instituto Valenciano de Oncología

Valencia, Spain

Royal Sussex County Hospital - University Hospitals Sussex NHS Foundation Trust

Brighton, United Kingdom

University Hospitals Bristol and Weston NHS Foundation Trust, Bristol Haematology & Oncology Centre

Bristol, United Kingdom

Hull and East Yorkshire Hospitals NHS Trust - Castle Hill Hospital

Cottingham, United Kingdom

Edinburgh Cancer Centre-Western General Hospital

Edinburgh, United Kingdom

St James's University Hospital - Leeds Teaching Hospitals NHS Trust

Leeds, United Kingdom

St Bartholomew's Hospital - Barts Health NHS Trust

London, United Kingdom

University College London Hospitals NHS Foundation Trust

London, United Kingdom

The Royal Free Hospital - Royal Free London NHS Foundation Trust

London, United Kingdom

Sarah Cannon Research Institute

London, United Kingdom

Churchill Hospital - Oxford University Hospitals NHS Foundation Trust

Oxford, United Kingdom

North Wales Cancer Treatment C - Glan Clwyd Hospital

Rhyl, United Kingdom

Southampton General Hospital - University Hospital Southampton NHS Foundation Trust

Southampton, United Kingdom

Royal Stoke University Hospital - University Hospitals of North Midlands NHS Trust

Stoke-on-Trent, United Kingdom

Torbay Hosptial, South Devon Healthcare NHS Foundation Trust

Torquay, United Kingdom

New Cross Hospital - The Royal Wolverhampton NHS Trust

Wolverhampton, United Kingdom

Trial contact

BioNTech clinical trials patient information

Contact information from ClinicalTrials.gov. Contact in English.

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/1/2026.